Blog
RSS FeedPosted by Michael Wonder on 18 Apr 2021
Cancer researcher David Thomas says more should be done attract big pharma
18 April 2021 - A Garvan Institute cancer researcher says the government needs to attract big pharmaceutical companies to Australia ...
Posted by Michael Wonder on 16 Apr 2021
AstraZeneca ChAdOx1-S COVID-19 vaccine
16 April 2021 - Third Australian case of thrombosis with thrombocytopenia likely linked to vaccine. ...
Posted by Michael Wonder on 15 Apr 2021
Central Coast woman’s death after COVID-19 vaccine being investigated
15 April 2021 - Federal health authorities are investigating the death of a woman days after she received a COVID-19 ...
Posted by Michael Wonder on 14 Apr 2021
New blow to rollout as Novavax Covid-19 vaccine hits supply hiccup
15 April 2021 - Australia’s vaccine rollout has been dealt another blow as Novavax confirms manufacturing supply shortages mean it ...
Posted by Michael Wonder on 14 Apr 2021
Novavax COVID-19 vaccine in Australia: When will we get it? And is it better than Pfizer?
14 April 2021 - Australia's sluggish vaccine rollout was last week thrown another curve ball, with new medical advice recommending ...
Posted by Michael Wonder on 14 Apr 2021
TGA accepts Telix’s prostate cancer imaging product submission and commences priority evaluation process
14 April 2021 - Telix is pleased to announce that the TGA has accepted the Company’s submission for the registration ...
Posted by Michael Wonder on 14 Apr 2021
TGA grants provisional determination to GSK for COVID-19 monoclonal antibody treatment - sotrovimab
14 April 2021 - The TGA has granted a provisional determination to GSK in relation to the monoclonal antibody treatment, ...
Posted by Michael Wonder on 14 Apr 2021
Batch release assessment of COVID-19 vaccines
14 April 2021 - The Therapeutic Goods Administration ensures there is an independent quality assessment of every batch of vaccine supplied ...
Posted by Michael Wonder on 13 Apr 2021
Did Australia get it right on AstraZeneca?
14 April 2021 - The almost-total absence of criticism for Australia’s decision to preference Pfizer’s vaccine over AstraZeneca’s for people ...
Posted by Michael Wonder on 10 Apr 2021
Doctors stop offering AstraZeneca jabs over legal risk
11 April 2021 - Many of the nation’s GPs are refusing to offer AstraZeneca’s vaccine to people under 50 until ...
Posted by Michael Wonder on 08 Apr 2021
ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns
8 April 2021 - A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on the AstraZeneca COVID-19 vaccine in ...
Posted by Michael Wonder on 08 Apr 2021
‘Before end of this year’: Novavax COVID vaccine could be months away
8 April 2021 - Regulatory approvals for the third pillar of Australia’s vaccine strategy may not be obtained until the ...
Posted by Michael Wonder on 08 Apr 2021
Wider storage and transportation conditions for the Pfizer COVID-19 vaccine now approved
8 April 2021 - The Therapeutic Goods Administration has recently approved wider storage and transportation conditions for the Pfizer COVID-19 ...
Posted by Michael Wonder on 07 Apr 2021
TGA to review advertising of stem cell therapies to the Australian public
7 April 2021 - The Therapeutic Goods Administration, part of the Department of Health, is investigating the advertising of stem ...
Posted by Michael Wonder on 06 Apr 2021
Statement by Acting Australian Government Chief Medical Officer, Professor Michael Kidd and Head of the Therapeutic Goods Administration Adjunct Professor John Skerritt
2 April 2021 - Australia's vaccine safety and regulatory process is world class and people can be confident that vaccines ...